Who owns Cassava Sciences, Inc.?
The parent company, the largest shareholders that report their holdings, the funds that own Cassava Sciences, Inc. and what its insiders traded, each from the filing that states it.
The short answer
Cassava Sciences, Inc. is a listed company: its shares trade on Frankfurt, so it is owned by its shareholders, and the GLEIF register names no parent company.
80 institutional investors that report to the SEC on Form 13F held $9 M of its shares on Sep 30, 2026.
The largest of them was Vanguard Capital Management LLC with 1,929,726 shares, followed by BlackRock, Inc. (1,446,715 shares) and Marshall Wace, LLP (1,161,405 shares).
19 mutual funds held 2.5% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's.
Newest figure: Sep 30, 2026.
Holdings reported on SEC Form 13F for the quarter ended Sep 30, 2026: 80 holders, together.
| # | Holder | Of the shares | Value | Shares | Change in the quarter |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management LLC | — | $2 M | 1.9 M | -2.3% |
| 2 | BlackRock, Inc. | — | $1 M | 1.4 M | -0.5% |
| 3 | Marshall Wace, LLP | — | $1 M | 1.2 M | -27.3% |
| 4 | Geode Capital Management, LLC | — | $1 M | 612,195 | -0.5% |
| 5 | GMT Capital Corp | — | $0 M | 450,100 | 0.0% |
| 6 | Gsa Capital Partners LLP | — | $0 M | 435,661 | +61.7% |
| 7 | Two Sigma Investments, LP | — | $0 M | 423,400 | -75.3% |
| 8 | Squarepoint Ops LLC | — | $0 M | 375,992 | +18.1% |
| 9 | Acadian Asset Management LLC | — | $0 M | 317,177 | +7.5% |
| 10 | Vanguard Fiduciary Trust Co | — | $0 M | 315,889 | 0.0% |
As of Sep 30, 2026
How ownership moved#
Institutions held — of Cassava Sciences, Inc. at Sep 30, 2026, 5 fewer institutions.
| Quarter end | Institutions | Share of the company | Shares bought | Shares sold | Positions opened | Positions closed |
|---|---|---|---|---|---|---|
| Sep 30, 2026(still being filed) | 80 | — | 533,804 | 2.8 M | 7 | 14 |
| Jun 30, 2026 | 85 | — | 1.5 M | 1.6 M | 8 | — |
| Mar 31, 2026 | 100 | — | — | — | — | — |
| Dec 31, 2025 | 105 | — | — | — | — | — |
| Sep 30, 2025 | 100 | — | — | — | — | — |
| Jun 30, 2025 | 97 | — | — | — | — | — |
| Mar 31, 2025 | 117 | — | — | — | — | — |
| Dec 31, 2024 | 137 | — | — | — | — | — |
| Sep 30, 2024 | 158 | — | — | — | — | — |
| Jun 30, 2024 | 146 | — | — | — | — | — |
| Mar 31, 2024 | 139 | — | — | — | — | — |
| Dec 31, 2023 | 152 | — | — | — | — | — |
| Sep 30, 2023 | 137 | — | — | — | — | — |
| Jun 30, 2023 | 147 | — | — | — | — | — |
| Mar 31, 2023 | 140 | — | — | — | — | — |
| Dec 31, 2022 | 149 | — | — | — | — | — |
| Sep 30, 2022 | 169 | — | — | — | — | — |
| Jun 30, 2022 | 144 | — | — | — | — | — |
| Mar 31, 2022 | 154 | — | — | — | — | — |
| Dec 31, 2021 | 166 | — | — | — | — | — |
| Sep 30, 2021 | 177 | — | — | — | — | — |
Bought most, quarter to Sep 30, 2026
- Gsa Capital Partners LLP+166,251
- Stifel Financial Corp+125,000
- Squarepoint Ops LLC+57,612
- Acadian Asset Management LLC+22,118
- UBS Group AG+20,628
- Jpmorgan Chase & Co+14,014
- Federated Hermes, Inc.+11,282
- FMR LLC+4,328
Sold most
- Two Sigma Investments, LP−1.3 M
- Goldman Sachs Group Inc−606,191
- Marshall Wace, LLP−436,143
- Renaissance Technologies LLC−167,242
- Susquehanna International Group, LLP−95,901
- Group One Trading LLC−46,848
- Vanguard Capital Management LLC−45,255
- Simplex Trading, LLC−44,180
New positions (shares held)
- HRT Financial LP72,709
- Bank Of America Corp /de/30,871
- Optiver Holding B.V.2,884
- Nuveen, LLC1,119
- Physician Wealth Advisors, Inc.581
- Arax Advisory Partners100
- Transamerica Financial Advisors, LLC35
19 funds held 2.5% of the company in their latest reports. Fund holdings are part of what their managers report on Form 13F, so do not add the two.
| Fund | Manager | Country | Of the company | Value | Report of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 1.20% | $2 M | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 0.50% | $1 M | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | Fidelity Management & Research Company LLC | 🇺🇸 | 0.25% | $0 M | May 31, 2026 |
| Vanguard Health Care Index Fund | The Vanguard Group, Inc. | 🇺🇸 | 0.12% | $0 M | May 31, 2026 |
| iShares Micro-Cap ETF | BlackRock Fund Advisors | 🇺🇸 | 0.13% | $0 M | Jun 30, 2026 |
As of Jul 31, 2026
Questions and answers#
Who owns Cassava Sciences, Inc.?
Cassava Sciences, Inc. is a listed company: its shares trade on Frankfurt, so it is owned by its shareholders, and the GLEIF register names no parent company. 80 institutional investors that report to the SEC on Form 13F held $9 M of its shares on Sep 30, 2026. The largest of them was Vanguard Capital Management LLC with 1,929,726 shares, followed by BlackRock, Inc. (1,446,715 shares) and Marshall Wace, LLP (1,161,405 shares).
Who is the largest shareholder of Cassava Sciences, Inc.?
Among investors that file SEC Form 13F, Vanguard Capital Management LLC was the largest on Sep 30, 2026. Founders, executives and other people who hold shares in their own name report them on SEC Forms 3, 4 and 5 and in the proxy statement, not on Form 13F, so they are not in this ranking.
Does Cassava Sciences, Inc. have a parent company?
No. The GLEIF register of legal entities names no parent company of Cassava Sciences, Inc.
Which mutual funds own Cassava Sciences, Inc.?
19 mutual funds held 2.5% of the company in their latest reports (the newest of Jul 31, 2026); the largest position was Vanguard Total Stock Market Index Fund's. Funds' holdings are part of what their managers report on Form 13F, so the two shares overlap.
More about Cassava Sciences, Inc.#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Oneness Biotech Co., Ltd.$520 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M